Evaluation of Dexmedetomidine's Effect on Temperature in Obese Critically Ill Patients.
Sara A AtyiaAnthony T GerlachKeaton S SmetanaMolly J ThompsonCasey C MayPublished in: Journal of pharmacy practice (2022)
This study suggests that there is a significant increase in body temperature from baseline for obese patients on DEX. Duration of DEX and baseline temperature were found to be risk factors for fever development in this population. Further studies are warranted.